J. Fungi 2014, 1(1), 1-3; doi:10.3390/jof1010001
Editorial

Welcome Message from the Editor-in-Chief

email
Received: 7 July 2014; Accepted: 7 July 2014 / Published: 16 July 2014
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Note: In lieu of an abstract, this is an excerpt from the first page.

Excerpt: Fungi are one of the most important and diverse groups of organisms on the planet, having a dual impact on humanity. They adversely impact human and animal health and can be a scourge to agriculture, while in turn serving as a beneficial source for foods and beverages, new medications, and biocontrol. There are approximately 1.5 million different species of fungi on Earth, which largely reside in soil and plant. They are also readily found on human skin and within the gastrointestinal and genitourinary tract, yet only about 300 species are known to make people sick [1,2]. Fungi are bountiful in the environment and we encounter them everyday, usually in the form of freely dispersed spores and hyphal fragments that we breath-in. Typically, encounters with fungi are harmless, as the human immune systems is well poised to handle such interactions. However, some fungal species pose significant health risks, such as endemic mycoses or those producing toxins like mycotoxins. Most importantly, immune dysfunction can lead to serious life-threatening diseases or severe fungal-induced allergic diseases such as asthma or other chronic conditions [3]. In fact, most invasive fungal diseases are associated with changes in the host such as immunosuppression, antibiotic-mediated disruption of microflora, or other immunosuppressing conditions resulting from HIV/AIDS and hematologic malignancies [3,4]. Such diseases require therapy with antifungal agents. Yet, there are only limited classes available to treat invasive fungal infection, and emerging drug resistance further restricts treatment options. In some cases, agents used to control agriculturally important moulds are the same class as those used to treat humans, and de novo resistance can emerge from the environment [5]. Fungi are not always easy to detect and cryptic chronic infections in the form of unculturable organisms can confound diagnosis [6]. [...]
PDF Full-text Download PDF Full-Text [338 KB, uploaded 16 July 2014 12:18 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Perlin, D.S. Welcome Message from the Editor-in-Chief. J. Fungi 2014, 1, 1-3.

AMA Style

Perlin DS. Welcome Message from the Editor-in-Chief. Journal of Fungi. 2014; 1(1):1-3.

Chicago/Turabian Style

Perlin, David S. 2014. "Welcome Message from the Editor-in-Chief." J. Fungi 1, no. 1: 1-3.

J. Fungi EISSN 2309-608X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert